Faculty

Institution

Unit

Venue

Amanda Bruegl, M.D.

Associate Professor of Obstetrics and Gynecology

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Obstetrics And Gynecology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Department Of Obstetrics And Gynecology

Division Of Gynecologic Oncology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Amanda Bruegl, M.d. is currently serving as a Biostatistics Shared Resources Associate Professor of Obstetrics and Gynecology at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Amanda Bruegl, M.D.

Oregon Health & Science University

Associate Professor of Obstetrics and Gynecology

You can click a keyword to filter the displayed items

gynecology gynecologic oncology oncology gynecologic cancers cancer care cervical cancer women's health public health pathology cancer screening molecular diagnostics preventive medicine obstetrics and gynaecology reproductive health cancer genetics cancer management gynecological surgery cancer detection human genetics surgical oncology molecular pathology epidemiology of cancer lynch syndrome clinical endpoint vulnerable patient populations cost-effectiveness analysis medical education health equity venereology cancer disparities health policy sexual health cancer risk genetic testing cancer-associated virus endometrial cancer health care indigenous peoples indigenous studies cancer prevention cost effectiveness endometrial cancer patients genetic counseling clinical evidence postmenopausal women health systems professional development diabetes care diabetes research health planning cancer biology diabetes epidemiology diabetes mellitus diabetes management genome instability gestational trophoblastic neoplasia hpv self-collection ethnic studies higher education allometric studies primary health care healthcare innovation traditional medicines professional ethics informed consent racial groups ethnic discrimination universal msi/ihc contemporary framework mlh1 methylation analysis type 2 first nation community gynecologic cancer incidence mendelian randomisation study adult height increased risk

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cytology and High-Risk Human Papillomavirus Testing Performance for Cervical Cancer Screening in Transmasculine Patients. Journal of Women s Health (2026)

cytopathologydiagnostic testscervical cancer screeningcancer carediagnosisgynecologic oncologygynecologic cancersoncologymolecular diagnosticscervical cancercancer screeningcancer-associated virustransmasculine patientspathologygynecologycancer detection

Female Allogeneic Hematopoietic Cell Transplantation Survivors Perspectives on Cervical Cancer Screening: A Retrospective Study. Transplantation and Cellular Therapy (2026)

medicineclinical transplantationcervical cancer screeningcancer carestem cell transplantationgynecologic oncologyretrospective studytransplantation medicineoncologybone marrow transplantationcervical cancercancer screeningreproductive healthgynecologywomen's health

Immunotherapy Induced Sarcoidosis in a 47-Year-Old Female With Stage Iiic Cervical Cancer on Pembrolizumab: A Case Report. Gynecologic Oncology Reports (2026)

immunologymedicineclinical diseasecancer immunotherapy47-year-old femalegynecologic cancersoncologycervical cancercase reportjama oncologypathologyimmunotherapy

A Cross-Sectional Study of Cervical Cancer Screening Rates Within a Large National Network of Community Health Organizations. Gynecologic Oncology (2025)

public healthlarge national networkhealth services researchcancer carepopulation healthpreventive healthcarecross-sectional studiespreventive medicinecancer screeningcervical cancerepidemiology of cancergynecology

Assessment of the Performance of Cervical Cancer Screening Methods in Transmasculine Patients. Gynecologic Oncology Reports (2025)

diagnostic testscancer careradiation oncologydiagnosisgynecologic oncologycancer imagingoncologycancer screeningcervical cancertransmasculine patientsgynecologycancer detection

Cervical Cancer Screening Rates Within a Large National Network of Community-Based Health Care Organizations: A Cross-Sectional Study. Journal of Women s Health (2025)

public healthlarge national networkvulnerable patient populationshealth services researchcancer carehealth planninghealth carepreventive healthcarecross-sectional studiespreventive medicinecancer screeningcervical cancergynecology

Hpv Vaccination in Community Health Organizations: What is Going Right and How Can It Be Replicated?. Cancer Causes & Control (2025)

public healthvaccinescommunicable diseasespublic health ethicsvaccine hesitancyepidemiologycommunity health organizationsvaccine efficacypreventive healthcarehpv vaccinationpreventive medicinevaccinationhealth policy

Human Papillomavirus (Hpv) Vaccination Rates Within a Large National Network of Community Health Organizations: A Cross-Sectional Study. Gynecologic Oncology Reports (2025)

public healthvaccinescommunicable diseaseslarge national networkvaccine hesitancyepidemiologyvaccine efficacypopulation healthcross-sectional studiespreventive medicinevaccinationvaccination ratespublic health interventions

Low Adherence to Cervical Cancer Screening Guidelines Among Women Survivors After Allogeneic Hematopoietic Cell Transplantation: Predictors and Practice Gaps From a Single-Center Analysis. Blood (2025)

outcomes researchhealth services researchclinical transplantationcancer carewomen survivorsgynecologic oncologyfamily medicinepreventive healthcarelow adherencepreventive medicinecancer screeningcervical cancergynecologysupportive carewomen's healthcancer disparities

Postpartum Hpv Vaccination is a Cost-Effective Strategy for Prevention of Cervical Dysplasia and Cancer. Gynecologic Oncology Reports (2025)

public healthvaccinescervical dysplasiaobstetrics and gynaecologyvaccine efficacypreventive healthcarecost-effective strategypreventive medicinecervical cancervaccinationvaccine safetypostpartum hpv vaccinationgynecology

1
2
3
4
5
10
10 / page

Amanda Bruegl, M.D.

Associate Professor of Obstetrics and Gynecology

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Obstetrics And Gynecology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Department Of Obstetrics And Gynecology

Division Of Gynecologic Oncology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Amanda Bruegl, M.d. is currently serving as a Biostatistics Shared Resources Associate Professor of Obstetrics and Gynecology at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Amanda Bruegl, M.D.

Oregon Health & Science University

Associate Professor of Obstetrics and Gynecology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Cytology and High-Risk Human Papillomavirus Testing Performance for Cervical Cancer Screening in Transmasculine Patients. Journal of Women s Health (2026)

Female Allogeneic Hematopoietic Cell Transplantation Survivors Perspectives on Cervical Cancer Screening: A Retrospective Study. Transplantation and Cellular Therapy (2026)

Immunotherapy Induced Sarcoidosis in a 47-Year-Old Female With Stage Iiic Cervical Cancer on Pembrolizumab: A Case Report. Gynecologic Oncology Reports (2026)

immunologymedicineclinical diseasecancer immunotherapy47-year-old femalegynecologic cancersoncologycervical cancercase reportjama oncologypathologyimmunotherapy

A Cross-Sectional Study of Cervical Cancer Screening Rates Within a Large National Network of Community Health Organizations. Gynecologic Oncology (2025)

Assessment of the Performance of Cervical Cancer Screening Methods in Transmasculine Patients. Gynecologic Oncology Reports (2025)

diagnostic testscancer careradiation oncologydiagnosisgynecologic oncologycancer imagingoncologycancer screeningcervical cancertransmasculine patientsgynecologycancer detection

Cervical Cancer Screening Rates Within a Large National Network of Community-Based Health Care Organizations: A Cross-Sectional Study. Journal of Women s Health (2025)

Hpv Vaccination in Community Health Organizations: What is Going Right and How Can It Be Replicated?. Cancer Causes & Control (2025)

Human Papillomavirus (Hpv) Vaccination Rates Within a Large National Network of Community Health Organizations: A Cross-Sectional Study. Gynecologic Oncology Reports (2025)

Postpartum Hpv Vaccination is a Cost-Effective Strategy for Prevention of Cervical Dysplasia and Cancer. Gynecologic Oncology Reports (2025)

1
2
3
4
5
10
10 / page